The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
Brucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-speci...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/3/654 |
_version_ | 1797608672417808384 |
---|---|
author | Ayman Elbehiry Musaad Aldubaib Eman Marzouk Adil Abalkhail Abdulaziz M. Almuzaini Mohammed Rawway Ali Alghamdi Abdullah Alqarni Mohammed Aldawsari Abdelmaged Draz |
author_facet | Ayman Elbehiry Musaad Aldubaib Eman Marzouk Adil Abalkhail Abdulaziz M. Almuzaini Mohammed Rawway Ali Alghamdi Abdullah Alqarni Mohammed Aldawsari Abdelmaged Draz |
author_sort | Ayman Elbehiry |
collection | DOAJ |
description | Brucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-specific manner, making laboratory confirmation of the diagnosis critical to the patient’s recovery. A coordinated strategy for diagnosing and controlling brucellosis throughout the Middle East is required, as this disease cannot be known to occur without reliable microbiological, molecular, and epidemiological evidence. Consequently, the current review focuses on the current and emerging microbiological diagnostic tools for the early detection and control of human brucellosis. Laboratory assays such as culturing, serology, and molecular analysis can frequently be used to diagnose brucellosis. Although serological markers and nucleic acid amplification techniques are extremely sensitive, and extensive experience has been gained with these techniques in the laboratory diagnosis of brucellosis, a culture is still considered to be the “gold standard” due to the importance of this aspect of public health and clinical care. In endemic regions, however, serological tests remain the primary method of diagnosis due to their low cost, user-friendliness, and strong ability to provide a negative prediction, so they are commonly used. A nucleic acid amplification assay, which is highly sensitive, specific, and safe, is capable of enabling rapid disease diagnosis. Patients who have reportedly fully healed may continue to have positive molecular test results for a long time. Therefore, cultures and serological methods will continue to be the main tools for diagnosing and following up on human brucellosis for as long as no commercial tests or studies demonstrate adequate interlaboratory reproducibility. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Over the past few decades, several studies have been conducted to develop <i>Brucella</i> vaccines, but the problem of controlling brucellosis in both humans and animals remains challenging. Therefore, this review also aims to present an updated overview of the different types of brucellosis vaccines that are currently available. |
first_indexed | 2024-03-11T05:46:51Z |
format | Article |
id | doaj.art-34b8e447558a40e894777f28b81c7459 |
institution | Directory Open Access Journal |
issn | 2076-393X |
language | English |
last_indexed | 2024-03-11T05:46:51Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj.art-34b8e447558a40e894777f28b81c74592023-11-17T14:19:06ZengMDPI AGVaccines2076-393X2023-03-0111365410.3390/vaccines11030654The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic AreasAyman Elbehiry0Musaad Aldubaib1Eman Marzouk2Adil Abalkhail3Abdulaziz M. Almuzaini4Mohammed Rawway5Ali Alghamdi6Abdullah Alqarni7Mohammed Aldawsari8Abdelmaged Draz9Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaDepartment of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaBiology Department, College of Science, Jouf University, Sakaka 42421, Saudi ArabiaDepartment of Optometry, King Fahad Armed Hospital, Jeddah 23311, Saudi ArabiaDepartment of Family Medicine, King Fahad Armed Hospital, Jeddah 23311, Saudi ArabiaDepartment of Medical services, Ministry of Defense, Riyadh 12426, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaBrucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-specific manner, making laboratory confirmation of the diagnosis critical to the patient’s recovery. A coordinated strategy for diagnosing and controlling brucellosis throughout the Middle East is required, as this disease cannot be known to occur without reliable microbiological, molecular, and epidemiological evidence. Consequently, the current review focuses on the current and emerging microbiological diagnostic tools for the early detection and control of human brucellosis. Laboratory assays such as culturing, serology, and molecular analysis can frequently be used to diagnose brucellosis. Although serological markers and nucleic acid amplification techniques are extremely sensitive, and extensive experience has been gained with these techniques in the laboratory diagnosis of brucellosis, a culture is still considered to be the “gold standard” due to the importance of this aspect of public health and clinical care. In endemic regions, however, serological tests remain the primary method of diagnosis due to their low cost, user-friendliness, and strong ability to provide a negative prediction, so they are commonly used. A nucleic acid amplification assay, which is highly sensitive, specific, and safe, is capable of enabling rapid disease diagnosis. Patients who have reportedly fully healed may continue to have positive molecular test results for a long time. Therefore, cultures and serological methods will continue to be the main tools for diagnosing and following up on human brucellosis for as long as no commercial tests or studies demonstrate adequate interlaboratory reproducibility. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Over the past few decades, several studies have been conducted to develop <i>Brucella</i> vaccines, but the problem of controlling brucellosis in both humans and animals remains challenging. Therefore, this review also aims to present an updated overview of the different types of brucellosis vaccines that are currently available.https://www.mdpi.com/2076-393X/11/3/654zoonotic brucellosishistorydiagnostic approachesvaccine developmentpublic health |
spellingShingle | Ayman Elbehiry Musaad Aldubaib Eman Marzouk Adil Abalkhail Abdulaziz M. Almuzaini Mohammed Rawway Ali Alghamdi Abdullah Alqarni Mohammed Aldawsari Abdelmaged Draz The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas Vaccines zoonotic brucellosis history diagnostic approaches vaccine development public health |
title | The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas |
title_full | The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas |
title_fullStr | The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas |
title_full_unstemmed | The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas |
title_short | The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas |
title_sort | development of diagnostic and vaccine strategies for early detection and control of human brucellosis particularly in endemic areas |
topic | zoonotic brucellosis history diagnostic approaches vaccine development public health |
url | https://www.mdpi.com/2076-393X/11/3/654 |
work_keys_str_mv | AT aymanelbehiry thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT musaadaldubaib thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT emanmarzouk thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT adilabalkhail thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdulazizmalmuzaini thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT mohammedrawway thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT alialghamdi thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdullahalqarni thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT mohammedaldawsari thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdelmageddraz thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT aymanelbehiry developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT musaadaldubaib developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT emanmarzouk developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT adilabalkhail developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdulazizmalmuzaini developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT mohammedrawway developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT alialghamdi developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdullahalqarni developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT mohammedaldawsari developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas AT abdelmageddraz developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas |